[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100154069":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":27,"centralContacts":37,"locations":42,"responsibleParty":69,"collaborators":72,"id":93,"slug":94,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":95,"sex":100,"minAge":10,"maxAge":10,"enrollmentInfo":101,"targetDuration":10,"studyType":104,"phases":10,"briefSummary":105,"conditions":106,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"Charite University, Berlin, Germany","OTHER",[8,12,15,18,21,24],{"label":9,"type":10,"description":11,"interventionNames":10},"Ankylosing spondylitis",null,"Ankylosing spondylitis according to the modified New York criteria or with the clinical diagnosis of AS\u002Fr-axSpA fulfilling the ASAS Classification Criteria AND the mNY criteria plus having the indiaction for starting a bDMARD therapy according to the treating rheumatologist",{"label":13,"type":10,"description":14,"interventionNames":10},"Non-radiographic axial spondyloarthritis","Patients with clinical characteristics of axial SpA but not fulfilling the modified New York criteria for which radiographic sacroiliitis is essential or with the clinical diagnosis of nr-axSpA fulfilling the ASAS Classification Criteria not fulfilling the mNY criteria and the indiaction for starting a bDMARD therapy according to the treating rheumatologist",{"label":16,"type":10,"description":17,"interventionNames":10},"Juvenile spondyloarthritis","Patients with juvenile spondyloarthritis (juvenile ankylosing spondylitis, juvenile non-AS-spondyloarthritis).",{"label":19,"type":10,"description":20,"interventionNames":10},"Crohn's disease","Patients with Crohn's disease",{"label":22,"type":10,"description":23,"interventionNames":10},"Acute anterior uveitis","Patients with acute anterior uveitis",{"label":25,"type":10,"description":26,"interventionNames":10},"Axial psoriatic arthritis","Patients with the clinical diagnosis of psoriatic arthritis with axial involvement (sacroiliac joints and\u002For spine) (axPsA)",[28,31,33,35],{"name":29,"affiliation":5,"role":30},"Joachim Sieper, Prof. Dr.","STUDY_CHAIR",{"name":32,"affiliation":5,"role":30},"Martin Rudwaleit, Prof. Dr.",{"name":34,"affiliation":5,"role":30},"Denis Poddubnyy, Prof. Dr.",{"name":36,"affiliation":5,"role":30},"Fabian Proft, MD",[38],{"name":34,"role":39,"phone":40,"phoneExt":10,"email":41},"CONTACT","+4930450514582","denis.poddubnyy@charite.de",[43],{"facility":44,"status":45,"city":46,"state":10,"zip":10,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Charité - Universitätsmedizin Berlin","RECRUITING","Berlin","Germany","DE",{"type":50,"coordinates":51},"Point",[52,53],13.41053,52.52437,{"lat":53,"lon":52},[56,59,62,65,67],{"name":57,"role":39,"phone":10,"phoneExt":10,"email":58},"Claudia Lorenz","Claudia.Lorenz@charite.de",{"name":60,"role":61,"phone":10,"phoneExt":10,"email":10},"Valeria Rios Rodriguez","PRINCIPAL_INVESTIGATOR",{"name":63,"role":64,"phone":10,"phoneExt":10,"email":10},"Mikhail Protopopov, Dr.","SUB_INVESTIGATOR",{"name":66,"role":61,"phone":10,"phoneExt":10,"email":10},"Judith Rademacher, Dr.",{"name":68,"role":64,"phone":10,"phoneExt":10,"email":10},"Murat Torgutalp, Dr.",{"type":61,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Denis Poddubnyy","Prof.",[73,76,79,81,83,85,87,89,91],{"name":74,"class":75},"German Federal Ministry of Education and Research","OTHER_GOV",{"name":77,"class":78},"AbbVie","INDUSTRY",{"name":80,"class":78},"Amgen",{"name":82,"class":78},"Centocor, Inc.",{"name":84,"class":78},"Schering-Plough",{"name":86,"class":78},"Wyeth is now a wholly owned subsidiary of Pfizer",{"name":88,"class":6},"Berlin Institute of Health",{"name":90,"class":78},"Novartis",{"name":92,"class":78},"UCB Pharma","100154069","german-spondyloarthritis-inception-cohort-100154069",false,"NCT01277419","German Spondyloarthritis Inception Cohort","GESPIC","Main inclusion Criteria:\n\n* Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis.\n* Patients with definite diagnosis of Crohn's disease.\n* Patients with definite diagnosis of acute anterior uveitis.\n* Patients with definite diagnosis of psoriatic arthritis with axial involvement.","ALL",{"count":102,"type":103},1000,"ESTIMATED","OBSERVATIONAL","The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA \u002F conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis \u002F axial psoriatic arthritis.",[107,108,109,110,111,112],"Ankylosing Spondylitis (AS) \u002F Radiographic Axial SpA (r-axSpA)","Non-radiographic Axial Spondyloarthritis (Nr-axSpA)","Axial Psoriatic Arthritis (axPsA)","Acute Anterior Uveitis (AAU)","Crohn Disease (CD)","Ulcerative Colitis (UC)","2021-10-05",{"date":115,"type":116},"2021-10-12","ACTUAL",{"date":118,"type":10},"2000-07",{"date":120,"type":103},"2030-07",{"name":5,"class":6},1]